nodes	percent_of_prediction	percent_of_DWPC	metapath
Apraclonidine—Oedema—Prednisolone—systemic lupus erythematosus	0.00134	0.00134	CcSEcCtD
Apraclonidine—Dizziness—Azathioprine—systemic lupus erythematosus	0.00134	0.00134	CcSEcCtD
Apraclonidine—Insomnia—Cyclosporine—systemic lupus erythematosus	0.00133	0.00133	CcSEcCtD
Apraclonidine—Paraesthesia—Cyclosporine—systemic lupus erythematosus	0.00132	0.00132	CcSEcCtD
Apraclonidine—Dyspnoea—Cyclosporine—systemic lupus erythematosus	0.00132	0.00132	CcSEcCtD
Apraclonidine—Somnolence—Cyclosporine—systemic lupus erythematosus	0.00131	0.00131	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic lupus erythematosus	0.00131	0.00131	CcSEcCtD
Apraclonidine—Oedema—Hydrocortisone—systemic lupus erythematosus	0.00131	0.00131	CcSEcCtD
Apraclonidine—Diarrhoea—Leflunomide—systemic lupus erythematosus	0.00131	0.00131	CcSEcCtD
Apraclonidine—Infection—Hydrocortisone—systemic lupus erythematosus	0.0013	0.0013	CcSEcCtD
Apraclonidine—Insomnia—Mycophenolate mofetil—systemic lupus erythematosus	0.0013	0.0013	CcSEcCtD
Apraclonidine—Paraesthesia—Mycophenolate mofetil—systemic lupus erythematosus	0.00129	0.00129	CcSEcCtD
Apraclonidine—Myalgia—Triamcinolone—systemic lupus erythematosus	0.00129	0.00129	CcSEcCtD
Apraclonidine—Vomiting—Azathioprine—systemic lupus erythematosus	0.00129	0.00129	CcSEcCtD
Apraclonidine—Nervous system disorder—Hydrocortisone—systemic lupus erythematosus	0.00129	0.00129	CcSEcCtD
Apraclonidine—Myalgia—Methylprednisolone—systemic lupus erythematosus	0.00129	0.00129	CcSEcCtD
Apraclonidine—Eye disorder—Prednisone—systemic lupus erythematosus	0.00128	0.00128	CcSEcCtD
Apraclonidine—Dyspnoea—Mycophenolate mofetil—systemic lupus erythematosus	0.00128	0.00128	CcSEcCtD
Apraclonidine—Somnolence—Mycophenolate mofetil—systemic lupus erythematosus	0.00128	0.00128	CcSEcCtD
Apraclonidine—Infestation NOS—Methotrexate—systemic lupus erythematosus	0.00128	0.00128	CcSEcCtD
Apraclonidine—Infestation—Methotrexate—systemic lupus erythematosus	0.00128	0.00128	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—systemic lupus erythematosus	0.00128	0.00128	CcSEcCtD
Apraclonidine—Dermatitis—Azathioprine—systemic lupus erythematosus	0.00128	0.00128	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	0.00127	0.00127	CcSEcCtD
Apraclonidine—Skin disorder—Hydrocortisone—systemic lupus erythematosus	0.00127	0.00127	CcSEcCtD
Apraclonidine—Ill-defined disorder—Dexamethasone—systemic lupus erythematosus	0.00127	0.00127	CcSEcCtD
Apraclonidine—Ill-defined disorder—Betamethasone—systemic lupus erythematosus	0.00127	0.00127	CcSEcCtD
Apraclonidine—Discomfort—Triamcinolone—systemic lupus erythematosus	0.00127	0.00127	CcSEcCtD
Apraclonidine—Fatigue—Cyclosporine—systemic lupus erythematosus	0.00127	0.00127	CcSEcCtD
Apraclonidine—Discomfort—Methylprednisolone—systemic lupus erythematosus	0.00127	0.00127	CcSEcCtD
Apraclonidine—Headache—Azathioprine—systemic lupus erythematosus	0.00127	0.00127	CcSEcCtD
Apraclonidine—Dizziness—Leflunomide—systemic lupus erythematosus	0.00126	0.00126	CcSEcCtD
Apraclonidine—Pain—Cyclosporine—systemic lupus erythematosus	0.00126	0.00126	CcSEcCtD
Apraclonidine—Constipation—Cyclosporine—systemic lupus erythematosus	0.00126	0.00126	CcSEcCtD
Apraclonidine—Dry mouth—Triamcinolone—systemic lupus erythematosus	0.00126	0.00126	CcSEcCtD
Apraclonidine—Angiopathy—Prednisone—systemic lupus erythematosus	0.00125	0.00125	CcSEcCtD
Apraclonidine—Conjunctivitis—Methotrexate—systemic lupus erythematosus	0.00124	0.00124	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.00124	0.00124	CcSEcCtD
Apraclonidine—Malaise—Dexamethasone—systemic lupus erythematosus	0.00124	0.00124	CcSEcCtD
Apraclonidine—Malaise—Betamethasone—systemic lupus erythematosus	0.00124	0.00124	CcSEcCtD
Apraclonidine—Oedema—Triamcinolone—systemic lupus erythematosus	0.00123	0.00123	CcSEcCtD
Apraclonidine—Syncope—Betamethasone—systemic lupus erythematosus	0.00123	0.00123	CcSEcCtD
Apraclonidine—Syncope—Dexamethasone—systemic lupus erythematosus	0.00123	0.00123	CcSEcCtD
Apraclonidine—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	0.00123	0.00123	CcSEcCtD
Apraclonidine—Pain—Mycophenolate mofetil—systemic lupus erythematosus	0.00123	0.00123	CcSEcCtD
Apraclonidine—Arrhythmia—Prednisone—systemic lupus erythematosus	0.00123	0.00123	CcSEcCtD
Apraclonidine—Infection—Triamcinolone—systemic lupus erythematosus	0.00123	0.00123	CcSEcCtD
Apraclonidine—Infection—Methylprednisolone—systemic lupus erythematosus	0.00122	0.00122	CcSEcCtD
Apraclonidine—Feeling abnormal—Cyclosporine—systemic lupus erythematosus	0.00122	0.00122	CcSEcCtD
Apraclonidine—Vomiting—Leflunomide—systemic lupus erythematosus	0.00122	0.00122	CcSEcCtD
Apraclonidine—Insomnia—Prednisolone—systemic lupus erythematosus	0.00121	0.00121	CcSEcCtD
Apraclonidine—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	0.00121	0.00121	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	0.00121	0.00121	CcSEcCtD
Apraclonidine—Paraesthesia—Prednisolone—systemic lupus erythematosus	0.00121	0.00121	CcSEcCtD
Apraclonidine—Dermatitis—Leflunomide—systemic lupus erythematosus	0.0012	0.0012	CcSEcCtD
Apraclonidine—Mental disorder—Prednisone—systemic lupus erythematosus	0.0012	0.0012	CcSEcCtD
Apraclonidine—Nausea—Azathioprine—systemic lupus erythematosus	0.0012	0.0012	CcSEcCtD
Apraclonidine—Headache—Leflunomide—systemic lupus erythematosus	0.0012	0.0012	CcSEcCtD
Apraclonidine—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.0012	0.0012	CcSEcCtD
Apraclonidine—Erythema—Prednisone—systemic lupus erythematosus	0.0012	0.0012	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	0.00119	0.00119	CcSEcCtD
Apraclonidine—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	0.00119	0.00119	CcSEcCtD
Apraclonidine—Insomnia—Hydrocortisone—systemic lupus erythematosus	0.00119	0.00119	CcSEcCtD
Apraclonidine—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	0.00118	0.00118	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.00118	0.00118	CcSEcCtD
Apraclonidine—Myalgia—Dexamethasone—systemic lupus erythematosus	0.00117	0.00117	CcSEcCtD
Apraclonidine—Myalgia—Betamethasone—systemic lupus erythematosus	0.00117	0.00117	CcSEcCtD
Apraclonidine—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.00117	0.00117	CcSEcCtD
Apraclonidine—Discomfort—Dexamethasone—systemic lupus erythematosus	0.00115	0.00115	CcSEcCtD
Apraclonidine—Discomfort—Betamethasone—systemic lupus erythematosus	0.00115	0.00115	CcSEcCtD
Apraclonidine—Pain—Prednisolone—systemic lupus erythematosus	0.00115	0.00115	CcSEcCtD
Apraclonidine—Haemorrhage—Methotrexate—systemic lupus erythematosus	0.00115	0.00115	CcSEcCtD
Apraclonidine—Pharyngitis—Methotrexate—systemic lupus erythematosus	0.00114	0.00114	CcSEcCtD
Apraclonidine—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.00114	0.00114	CcSEcCtD
Apraclonidine—Nausea—Leflunomide—systemic lupus erythematosus	0.00114	0.00114	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.00113	0.00113	CcSEcCtD
Apraclonidine—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.00113	0.00113	CcSEcCtD
Apraclonidine—Vision blurred—Prednisone—systemic lupus erythematosus	0.00113	0.00113	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.00112	0.00112	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.00112	0.00112	CcSEcCtD
Apraclonidine—Pain—Hydrocortisone—systemic lupus erythematosus	0.00112	0.00112	CcSEcCtD
Apraclonidine—Oedema—Dexamethasone—systemic lupus erythematosus	0.00112	0.00112	CcSEcCtD
Apraclonidine—Oedema—Betamethasone—systemic lupus erythematosus	0.00112	0.00112	CcSEcCtD
Apraclonidine—Insomnia—Triamcinolone—systemic lupus erythematosus	0.00112	0.00112	CcSEcCtD
Apraclonidine—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.00111	0.00111	CcSEcCtD
Apraclonidine—Infection—Dexamethasone—systemic lupus erythematosus	0.00111	0.00111	CcSEcCtD
Apraclonidine—Infection—Betamethasone—systemic lupus erythematosus	0.00111	0.00111	CcSEcCtD
Apraclonidine—Ill-defined disorder—Prednisone—systemic lupus erythematosus	0.00111	0.00111	CcSEcCtD
Apraclonidine—Paraesthesia—Triamcinolone—systemic lupus erythematosus	0.00111	0.00111	CcSEcCtD
Apraclonidine—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.00111	0.00111	CcSEcCtD
Apraclonidine—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	0.00111	0.00111	CcSEcCtD
Apraclonidine—Visual impairment—Methotrexate—systemic lupus erythematosus	0.00111	0.00111	CcSEcCtD
Apraclonidine—Dyspnoea—Triamcinolone—systemic lupus erythematosus	0.0011	0.0011	CcSEcCtD
Apraclonidine—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.0011	0.0011	CcSEcCtD
Apraclonidine—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.0011	0.0011	CcSEcCtD
Apraclonidine—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.00109	0.00109	CcSEcCtD
Apraclonidine—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.00108	0.00108	CcSEcCtD
Apraclonidine—Malaise—Prednisone—systemic lupus erythematosus	0.00108	0.00108	CcSEcCtD
Apraclonidine—Eye disorder—Methotrexate—systemic lupus erythematosus	0.00107	0.00107	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.00107	0.00107	CcSEcCtD
Apraclonidine—Syncope—Prednisone—systemic lupus erythematosus	0.00107	0.00107	CcSEcCtD
Apraclonidine—Fatigue—Triamcinolone—systemic lupus erythematosus	0.00106	0.00106	CcSEcCtD
Apraclonidine—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.00106	0.00106	CcSEcCtD
Apraclonidine—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.00106	0.00106	CcSEcCtD
Apraclonidine—Asthenia—Cyclosporine—systemic lupus erythematosus	0.00106	0.00106	CcSEcCtD
Apraclonidine—Pain—Triamcinolone—systemic lupus erythematosus	0.00106	0.00106	CcSEcCtD
Apraclonidine—Pruritus—Cyclosporine—systemic lupus erythematosus	0.00104	0.00104	CcSEcCtD
Apraclonidine—Angiopathy—Methotrexate—systemic lupus erythematosus	0.00104	0.00104	CcSEcCtD
Apraclonidine—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.00104	0.00104	CcSEcCtD
Apraclonidine—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	0.00103	0.00103	CcSEcCtD
Apraclonidine—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.00103	0.00103	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.00102	0.00102	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.00102	0.00102	CcSEcCtD
Apraclonidine—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.00102	0.00102	CcSEcCtD
Apraclonidine—Myalgia—Prednisone—systemic lupus erythematosus	0.00102	0.00102	CcSEcCtD
Apraclonidine—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.00102	0.00102	CcSEcCtD
Apraclonidine—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.00102	0.00102	CcSEcCtD
Apraclonidine—Insomnia—Dexamethasone—systemic lupus erythematosus	0.00101	0.00101	CcSEcCtD
Apraclonidine—Insomnia—Betamethasone—systemic lupus erythematosus	0.00101	0.00101	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.00101	0.00101	CcSEcCtD
Apraclonidine—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.00101	0.00101	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.00101	0.00101	CcSEcCtD
Apraclonidine—Paraesthesia—Dexamethasone—systemic lupus erythematosus	0.00101	0.00101	CcSEcCtD
Apraclonidine—Paraesthesia—Betamethasone—systemic lupus erythematosus	0.00101	0.00101	CcSEcCtD
Apraclonidine—Discomfort—Prednisone—systemic lupus erythematosus	0.00101	0.00101	CcSEcCtD
Apraclonidine—Mental disorder—Methotrexate—systemic lupus erythematosus	0.00101	0.00101	CcSEcCtD
Apraclonidine—Erythema—Methotrexate—systemic lupus erythematosus	0.000999	0.000999	CcSEcCtD
Apraclonidine—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000989	0.000989	CcSEcCtD
Apraclonidine—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000985	0.000985	CcSEcCtD
Apraclonidine—Dysgeusia—Methotrexate—systemic lupus erythematosus	0.000978	0.000978	CcSEcCtD
Apraclonidine—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000976	0.000976	CcSEcCtD
Apraclonidine—Oedema—Prednisone—systemic lupus erythematosus	0.000976	0.000976	CcSEcCtD
Apraclonidine—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.000974	0.000974	CcSEcCtD
Apraclonidine—Infection—Prednisone—systemic lupus erythematosus	0.000969	0.000969	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000967	0.000967	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000967	0.000967	CcSEcCtD
Apraclonidine—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.000966	0.000966	CcSEcCtD
Apraclonidine—Fatigue—Betamethasone—systemic lupus erythematosus	0.000966	0.000966	CcSEcCtD
Apraclonidine—Fatigue—Dexamethasone—systemic lupus erythematosus	0.000966	0.000966	CcSEcCtD
Apraclonidine—Pain—Betamethasone—systemic lupus erythematosus	0.000958	0.000958	CcSEcCtD
Apraclonidine—Pain—Dexamethasone—systemic lupus erythematosus	0.000958	0.000958	CcSEcCtD
Apraclonidine—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.000957	0.000957	CcSEcCtD
Apraclonidine—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000952	0.000952	CcSEcCtD
Apraclonidine—Skin disorder—Prednisone—systemic lupus erythematosus	0.000948	0.000948	CcSEcCtD
Apraclonidine—Vision blurred—Methotrexate—systemic lupus erythematosus	0.000942	0.000942	CcSEcCtD
Apraclonidine—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000941	0.000941	CcSEcCtD
Apraclonidine—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000938	0.000938	CcSEcCtD
Apraclonidine—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000929	0.000929	CcSEcCtD
Apraclonidine—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000928	0.000928	CcSEcCtD
Apraclonidine—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	0.000927	0.000927	CcSEcCtD
Apraclonidine—Headache—Cyclosporine—systemic lupus erythematosus	0.000924	0.000924	CcSEcCtD
Apraclonidine—Feeling abnormal—Betamethasone—systemic lupus erythematosus	0.000923	0.000923	CcSEcCtD
Apraclonidine—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	0.000923	0.000923	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	0.000916	0.000916	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	0.000916	0.000916	CcSEcCtD
Apraclonidine—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000915	0.000915	CcSEcCtD
Apraclonidine—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.00091	0.00091	CcSEcCtD
Apraclonidine—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.000908	0.000908	CcSEcCtD
Apraclonidine—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000907	0.000907	CcSEcCtD
Apraclonidine—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000902	0.000902	CcSEcCtD
Apraclonidine—Malaise—Methotrexate—systemic lupus erythematosus	0.000901	0.000901	CcSEcCtD
Apraclonidine—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000897	0.000897	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	0.000889	0.000889	CcSEcCtD
Apraclonidine—Dizziness—Prednisolone—systemic lupus erythematosus	0.000888	0.000888	CcSEcCtD
Apraclonidine—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000886	0.000886	CcSEcCtD
Apraclonidine—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.000886	0.000886	CcSEcCtD
Apraclonidine—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.000886	0.000886	CcSEcCtD
Apraclonidine—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000884	0.000884	CcSEcCtD
Apraclonidine—Insomnia—Prednisone—systemic lupus erythematosus	0.000882	0.000882	CcSEcCtD
Apraclonidine—Nausea—Cyclosporine—systemic lupus erythematosus	0.000876	0.000876	CcSEcCtD
Apraclonidine—Paraesthesia—Prednisone—systemic lupus erythematosus	0.000876	0.000876	CcSEcCtD
Apraclonidine—Pruritus—Triamcinolone—systemic lupus erythematosus	0.000874	0.000874	CcSEcCtD
Apraclonidine—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000872	0.000872	CcSEcCtD
Apraclonidine—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000867	0.000867	CcSEcCtD
Apraclonidine—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000855	0.000855	CcSEcCtD
Apraclonidine—Chest pain—Methotrexate—systemic lupus erythematosus	0.000851	0.000851	CcSEcCtD
Apraclonidine—Myalgia—Methotrexate—systemic lupus erythematosus	0.000851	0.000851	CcSEcCtD
Apraclonidine—Dermatitis—Prednisolone—systemic lupus erythematosus	0.000846	0.000846	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.000845	0.000845	CcSEcCtD
Apraclonidine—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000843	0.000843	CcSEcCtD
Apraclonidine—Fatigue—Prednisone—systemic lupus erythematosus	0.000841	0.000841	CcSEcCtD
Apraclonidine—Headache—Prednisolone—systemic lupus erythematosus	0.000841	0.000841	CcSEcCtD
Apraclonidine—Discomfort—Methotrexate—systemic lupus erythematosus	0.00084	0.00084	CcSEcCtD
Apraclonidine—Constipation—Prednisone—systemic lupus erythematosus	0.000834	0.000834	CcSEcCtD
Apraclonidine—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000834	0.000834	CcSEcCtD
Apraclonidine—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000826	0.000826	CcSEcCtD
Apraclonidine—Headache—Hydrocortisone—systemic lupus erythematosus	0.000821	0.000821	CcSEcCtD
Apraclonidine—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000816	0.000816	CcSEcCtD
Apraclonidine—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000815	0.000815	CcSEcCtD
Apraclonidine—Infection—Methotrexate—systemic lupus erythematosus	0.00081	0.00081	CcSEcCtD
Apraclonidine—Feeling abnormal—Prednisone—systemic lupus erythematosus	0.000804	0.000804	CcSEcCtD
Apraclonidine—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000804	0.000804	CcSEcCtD
Apraclonidine—Asthenia—Betamethasone—systemic lupus erythematosus	0.000804	0.000804	CcSEcCtD
Apraclonidine—Nervous system disorder—Methotrexate—systemic lupus erythematosus	0.0008	0.0008	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	0.000798	0.000798	CcSEcCtD
Apraclonidine—Nausea—Prednisolone—systemic lupus erythematosus	0.000797	0.000797	CcSEcCtD
Apraclonidine—Pruritus—Dexamethasone—systemic lupus erythematosus	0.000793	0.000793	CcSEcCtD
Apraclonidine—Pruritus—Betamethasone—systemic lupus erythematosus	0.000793	0.000793	CcSEcCtD
Apraclonidine—Skin disorder—Methotrexate—systemic lupus erythematosus	0.000792	0.000792	CcSEcCtD
Apraclonidine—Vomiting—Triamcinolone—systemic lupus erythematosus	0.000785	0.000785	CcSEcCtD
Apraclonidine—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000783	0.000783	CcSEcCtD
Apraclonidine—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000779	0.000779	CcSEcCtD
Apraclonidine—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000778	0.000778	CcSEcCtD
Apraclonidine—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.000776	0.000776	CcSEcCtD
Apraclonidine—Headache—Triamcinolone—systemic lupus erythematosus	0.000773	0.000773	CcSEcCtD
Apraclonidine—Headache—Methylprednisolone—systemic lupus erythematosus	0.000772	0.000772	CcSEcCtD
Apraclonidine—Abdominal pain—Prednisone—systemic lupus erythematosus	0.000771	0.000771	CcSEcCtD
Apraclonidine—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000766	0.000766	CcSEcCtD
Apraclonidine—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000766	0.000766	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	0.000743	0.000743	CcSEcCtD
Apraclonidine—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000741	0.000741	CcSEcCtD
Apraclonidine—Dizziness—Betamethasone—systemic lupus erythematosus	0.000741	0.000741	CcSEcCtD
Apraclonidine—Insomnia—Methotrexate—systemic lupus erythematosus	0.000737	0.000737	CcSEcCtD
Apraclonidine—Nausea—Triamcinolone—systemic lupus erythematosus	0.000733	0.000733	CcSEcCtD
Apraclonidine—Paraesthesia—Methotrexate—systemic lupus erythematosus	0.000732	0.000732	CcSEcCtD
Apraclonidine—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000732	0.000732	CcSEcCtD
Apraclonidine—Dyspnoea—Methotrexate—systemic lupus erythematosus	0.000727	0.000727	CcSEcCtD
Apraclonidine—Somnolence—Methotrexate—systemic lupus erythematosus	0.000725	0.000725	CcSEcCtD
Apraclonidine—Hypersensitivity—Prednisone—systemic lupus erythematosus	0.000719	0.000719	CcSEcCtD
Apraclonidine—Vomiting—Dexamethasone—systemic lupus erythematosus	0.000712	0.000712	CcSEcCtD
Apraclonidine—Vomiting—Betamethasone—systemic lupus erythematosus	0.000712	0.000712	CcSEcCtD
Apraclonidine—Dermatitis—Dexamethasone—systemic lupus erythematosus	0.000706	0.000706	CcSEcCtD
Apraclonidine—Dermatitis—Betamethasone—systemic lupus erythematosus	0.000706	0.000706	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	0.000704	0.000704	CcSEcCtD
Apraclonidine—Fatigue—Methotrexate—systemic lupus erythematosus	0.000703	0.000703	CcSEcCtD
Apraclonidine—Headache—Dexamethasone—systemic lupus erythematosus	0.000702	0.000702	CcSEcCtD
Apraclonidine—Headache—Betamethasone—systemic lupus erythematosus	0.000702	0.000702	CcSEcCtD
Apraclonidine—Asthenia—Prednisone—systemic lupus erythematosus	0.0007	0.0007	CcSEcCtD
Apraclonidine—Pain—Methotrexate—systemic lupus erythematosus	0.000697	0.000697	CcSEcCtD
Apraclonidine—Pruritus—Prednisone—systemic lupus erythematosus	0.00069	0.00069	CcSEcCtD
Apraclonidine—Feeling abnormal—Methotrexate—systemic lupus erythematosus	0.000672	0.000672	CcSEcCtD
Apraclonidine—Diarrhoea—Prednisone—systemic lupus erythematosus	0.000668	0.000668	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	0.000667	0.000667	CcSEcCtD
Apraclonidine—Nausea—Betamethasone—systemic lupus erythematosus	0.000665	0.000665	CcSEcCtD
Apraclonidine—Nausea—Dexamethasone—systemic lupus erythematosus	0.000665	0.000665	CcSEcCtD
Apraclonidine—Dizziness—Prednisone—systemic lupus erythematosus	0.000645	0.000645	CcSEcCtD
Apraclonidine—Abdominal pain—Methotrexate—systemic lupus erythematosus	0.000645	0.000645	CcSEcCtD
Apraclonidine—Vomiting—Prednisone—systemic lupus erythematosus	0.00062	0.00062	CcSEcCtD
Apraclonidine—Dermatitis—Prednisone—systemic lupus erythematosus	0.000615	0.000615	CcSEcCtD
Apraclonidine—Headache—Prednisone—systemic lupus erythematosus	0.000611	0.000611	CcSEcCtD
Apraclonidine—Hypersensitivity—Methotrexate—systemic lupus erythematosus	0.000601	0.000601	CcSEcCtD
Apraclonidine—Asthenia—Methotrexate—systemic lupus erythematosus	0.000585	0.000585	CcSEcCtD
Apraclonidine—Nausea—Prednisone—systemic lupus erythematosus	0.000579	0.000579	CcSEcCtD
Apraclonidine—Pruritus—Methotrexate—systemic lupus erythematosus	0.000577	0.000577	CcSEcCtD
Apraclonidine—Diarrhoea—Methotrexate—systemic lupus erythematosus	0.000558	0.000558	CcSEcCtD
Apraclonidine—Dizziness—Methotrexate—systemic lupus erythematosus	0.000539	0.000539	CcSEcCtD
Apraclonidine—Vomiting—Methotrexate—systemic lupus erythematosus	0.000518	0.000518	CcSEcCtD
Apraclonidine—Dermatitis—Methotrexate—systemic lupus erythematosus	0.000514	0.000514	CcSEcCtD
Apraclonidine—Headache—Methotrexate—systemic lupus erythematosus	0.000511	0.000511	CcSEcCtD
Apraclonidine—Nausea—Methotrexate—systemic lupus erythematosus	0.000484	0.000484	CcSEcCtD
